Kuros Biosciences(GB:0RHR)
CHF 19.43+0.15 (+0.78%)
GB:0RHR
Kuros Biosciences financials statements
CHF 19.43
At close:+0.15 (+0.78%)
Kuros Biosciences (0RHR) Income Statement
3 Followers
Kuros Biosciences Income Statement
Last quarter (Q2 2026), Kuros Biosciences's total revenue was CHF72.67M, an increase of 128.21% from the same quarter last year. In Q2, Kuros Biosciences's net income was CHF3.47M. See Kuros Biosciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| CHF 121.30M | CHF 75.56M | CHF 33.56M | CHF 17.99M | CHF 13.81M | |
| CHF 104.79M | CHF 62.03M | CHF 23.94M | CHF 10.77M | CHF 10.07M | |
| CHF 97.47M | CHF 67.03M | CHF 38.09M | CHF 24.21M | CHF 18.83M | |
| Depreciation and Amortization | CHF 2.68M | CHF 2.66M | CHF 2.75M | CHF 2.83M | CHF 2.88M |
| CHF 10.01M | CHF -537.00K | CHF -6.84M | CHF -8.84M | CHF -5.29M | |
| CHF 7.33M | CHF -5.00M | CHF -13.19M | CHF -13.45M | CHF -8.77M | |
| CHF -3.16M | CHF 1.65M | CHF -155.00K | CHF -2.54M | CHF -787.00K | |
| CHF 4.16M | CHF -3.35M | CHF -9.78M | CHF -15.99M | CHF -9.55M | |
| CHF 2.12M | CHF -3.72M | CHF -13.73M | CHF -14.60M | CHF -7.54M | |
| Per Share Metrics | |||||
| Basic EPS | CHF 0.06 | CHF -0.10 | CHF -0.38 | CHF -0.43 | CHF -0.23 |
| Diluted EPS | CHF 0.05 | CHF -0.10 | CHF -0.38 | CHF -0.43 | CHF -0.23 |
| Weighted Average Shares Outstanding | 38.44M | 37.20M | 36.58M | 33.90M | 32.79M |
| Weighted Average Shares Outstanding (Diluted) | 41.39M | 37.20M | 36.58M | 33.90M | 32.79M |
Currency in CHF

